Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-25

Clinical Trial Update: The Efficacy of Intralesional Bleomycin as Compared to 5-Flourouracil (5-FU) and Triamcinolone Acetonide (TAC) for the Treatment of Keloids: A Randomized Control Trial. [NA]

View source ↗

Summary

A randomized controlled trial comparing intralesional bleomycin to 5-FU and triamcinolone acetonide for treating keloids; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-Fluorouracil (5-FU)
  • Bleomycin (bleomycin)
  • TRIAMCINOLONE ACETONIDE (TRIAMCINOLONE ACETONIDE)

Snippet

Sponsor: King Edward Medical University | Conditions: Keloids Scars | NA | Status: NOT_YET_RECRUITING